Complementary and alternative medicines in prostate cancer: from bench to bedside? - Wikidata - awgldk - TriplyDB

Complementary and alternative medicines in prostate cancer: from bench to bedside?

Complementary and alternative medicines in prostate cancer: from bench to bedside?

http://www.wikidata.org/entity/Q36051522

about

Potential Effects of Pomegranate Polyphenols in Cancer Prevention and Therapy The use of dietary supplements to alleviate androgen deprivation therapy side effects during prostate cancer treatment Restoration of the anti-proliferative and anti-migratory effects of 1,25-dihydroxyvitamin D by silibinin in vitamin D-resistant colon cancer cells.Traditional Chinese medicine in the prevention and treatment of cancer and cancer metastasis.A Systematic Review of Randomized Controlled Trials on Oral Chinese Herbal Medicine for Prostate Cancer.Future directions in the prevention of prostate cancer.Nanoformulation of natural products for prevention and therapy of prostate cancer.Resveratrol in prostate diseases.Complementary and alternative medicine (CAM) in prostate and bladder cancer.Fish-Derived Omega-3 Fatty Acids and Prostate Cancer: A Systematic Review.Ethanolic Extract of Polish Propolis: Chemical Composition and TRAIL-R2 Death Receptor Targeting Apoptotic Activity against Prostate Cancer Cells The constituents of licorice (Glycyrrhiza uralensis) differentially suppress nitric oxide production in interleukin-1β-treated hepatocytes.A new flavanone and other flavonoids from green perilla leaf extract inhibit nitric oxide production in interleukin 1β-treated hepatocytes.

P2860

Q26800877-1F1C57FC-CDFA-4E81-93B0-618D971762EB Q34411758-C8949ED1-20E2-4C00-B553-13F10D1F32BB Q35568534-CF14D90B-C38F-4182-8355-34C18C90A026 Q35942893-9C820B56-F183-4A9A-83CA-E25F67448D3D Q36094649-2A0326CD-440B-4EC0-A4D7-38C96281B7E6 Q37279094-DE2561AA-8F83-4502-A9D7-CF6FEE83D29F Q37473193-0DDA9C5E-DE4D-4478-9576-06269A8B8BBD Q37605683-A83DA6B2-7ADF-4B58-B97F-3A04D9BB68C6 Q38128885-F6965063-B72B-499D-9E58-96CC1360BC4D Q38882859-95A8458D-9E93-4345-A3F9-ADD052B5C2FC Q42857689-31F085CA-91F4-4EBC-BBEF-0ED16A34D7ED Q43942270-109D5AC0-3FC1-409B-8CCC-8AAC10B7798A Q45818038-30DA7895-591B-4FC7-BE93-BB1A83DAE5B1

P2860

Complementary and alternative medicines in prostate cancer: from bench to bedside?

http://www.wikidata.org/entity/Q36051522

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Complementary and alternative medicines in prostate cancer: from bench to bedside?

@ast

Complementary and alternative medicines in prostate cancer: from bench to bedside?

@en

type

label

Complementary and alternative medicines in prostate cancer: from bench to bedside?

@ast

Complementary and alternative medicines in prostate cancer: from bench to bedside?

@en

prefLabel

Complementary and alternative medicines in prostate cancer: from bench to bedside?

@ast

Complementary and alternative medicines in prostate cancer: from bench to bedside?

@en

P1433

Q36051522-AA5148C0-01F4-48E6-A918-5499218A139E

P1476

Q36051522-17351903-A69E-4A36-96F7-3ED3509851FB

P2093

Q36051522-8D5BF2EF-FABC-40F8-AEC8-1C9424AE5399

P2860

Q36051522-0205A142-8742-400E-97AE-ED165871D122

Q36051522-053539E6-5007-44B4-A5EE-74F52E24A5B4

Q36051522-0641F38D-E788-4F6D-B2CB-B03CF58A0530

Q36051522-08ADCECD-0FF4-463D-9087-11FC11E68DD0

Q36051522-0B3223A2-6C82-46A6-AE79-E0FB6DC1E63F

Q36051522-0E10C699-EAB4-42F7-9270-521552D43739

Q36051522-0F1D4FD0-19B2-4B65-8215-0D1B9F5C2143

Q36051522-0F9BC4E7-A2A8-49FA-BD1A-CAE68946F8C7

Q36051522-1083B1CF-839A-4CBB-A8D6-F028F497388B

Q36051522-1132C7E7-9C87-4FED-9BBA-A1ACB3C3ED9D

P304

Q36051522-7637F9A7-2A2B-4553-8861-4F74EC9ADB24

P31

Q36051522-FD8B9962-3881-4645-B20F-FD771F519180

P356

Q36051522-15D19715-7A43-4BE5-A484-BEBF53F2642F

P433

Q36051522-13E2975D-BE19-4BEF-964B-83D2A39144DB

P478

Q36051522-87F20DA7-600E-4582-B085-BC2454F4681D

P50

Q36051522-B0CAEF9D-1DA0-4620-93DD-1DC8326C7184

P577

Q36051522-2864FA07-EDDB-46B1-98C4-F0B688093F09

P5875

Q36051522-C8329849-505D-47A9-8736-48CB35372BB3

P698

Q36051522-EF1DA9D3-92AA-4F3F-B6D3-0F206DD97D4F

P932

Q36051522-FCBC87F0-BB60-4CAC-BA45-532440C3C9AE

P356

THEONCOLOGIST.2012-0094

P1433

P1476

Complementary and alternative medicines in prostate cancer: from bench to bedside?

@en

P2093

Glenn Bubley

http://www.w3.org/2001/XMLSchema#string

P2860

Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases

Gemcitabine sensitivity can be induced in pancreatic cancer cells through modulation of miR-200 and miR-21 expression by curcumin or its analogue CDF

Hormonal control of androgen receptor function through SIRT1

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

Oxidative DNA damage: mechanisms, mutation, and disease

Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals

Green tea composition, consumption, and polyphenol chemistry

Cancer chemopreventive activity of resveratrol, a natural product derived from grapes

Curcumin inhibits the mammalian target of rapamycin-mediated signaling pathways in cancer cells

Selective cancer cell killing by alpha-tocopheryl succinate

P304

830-837

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1634/THEONCOLOGIST.2012-0094

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P50

Samuel J Klempner

P577

2012-05-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

225041499

http://www.w3.org/2001/XMLSchema#string

P698

22618569

http://www.w3.org/2001/XMLSchema#string

P932

3380882

http://www.w3.org/2001/XMLSchema#string